Rhenman & Partners Asset Management AB as of June 30, 2025
Portfolio Holdings for Rhenman & Partners Asset Management AB
Rhenman & Partners Asset Management AB holds 90 positions in its portfolio as reported in the June 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Eli Lilly & Co. (LLY) | 5.7 | $45M | 58k | 779.53 | |
| Boston Scientific Corporation (BSX) | 4.0 | $32M | 296k | 107.41 | |
| Vertex Pharmaceuticals Incorporated (VRTX) | 3.5 | $27M | 62k | 445.20 | |
| Glaukos (GKOS) | 3.1 | $24M | 235k | 103.29 | |
| Intuitive Surgical Com New (ISRG) | 3.0 | $24M | 44k | 543.41 | |
| Tenet Healthcare Corp Com New (THC) | 3.0 | $24M | 136k | 176.00 | |
| Danaher Corporation (DHR) | 3.0 | $24M | 122k | 197.54 | |
| CVS Caremark Corporation (CVS) | 2.6 | $20M | 295k | 68.98 | |
| McKesson Corporation (MCK) | 2.6 | $20M | 28k | 732.78 | |
| Neurocrine Biosciences (NBIX) | 2.4 | $19M | 149k | 125.69 | |
| Gilead Sciences (GILD) | 2.4 | $19M | 168k | 110.87 | |
| EXACT Sciences Corporation (EXAS) | 2.4 | $19M | 350k | 53.14 | |
| Alignment Healthcare (ALHC) | 2.3 | $18M | 1.3M | 14.00 | |
| Insmed Com Par $.01 (INSM) | 2.2 | $18M | 175k | 100.64 | |
| Anthem (ELV) | 2.2 | $17M | 45k | 388.96 | |
| Encompass Health Corp (EHC) | 2.1 | $17M | 136k | 122.63 | |
| Alnylam Pharmaceuticals (ALNY) | 2.1 | $17M | 51k | 326.09 | |
| Medtronic SHS (MDT) | 2.0 | $16M | 180k | 87.17 | |
| AmerisourceBergen (COR) | 1.9 | $15M | 49k | 299.85 | |
| Regeneron Pharmaceuticals (REGN) | 1.8 | $15M | 28k | 525.00 | |
| Insulet Corporation (PODD) | 1.8 | $15M | 46k | 314.18 | |
| Dex (DXCM) | 1.8 | $14M | 160k | 87.29 | |
| Abbvie (ABBV) | 1.6 | $13M | 69k | 185.62 | |
| Align Technology (ALGN) | 1.6 | $13M | 67k | 189.33 | |
| Royalty Pharma Shs Class A (RPRX) | 1.6 | $12M | 344k | 36.03 | |
| Cooper Cos (COO) | 1.5 | $12M | 170k | 71.16 | |
| Jazz Pharmaceuticals Shs Usd (JAZZ) | 1.5 | $12M | 109k | 106.12 | |
| Hca Holdings (HCA) | 1.4 | $11M | 30k | 383.10 | |
| Procept Biorobotics Corp (PRCT) | 1.4 | $11M | 190k | 57.60 | |
| Cigna Corp (CI) | 1.3 | $11M | 32k | 330.58 | |
| Akero Therapeutics (AKRO) | 1.3 | $11M | 198k | 53.36 | |
| Verona Pharma Sponsored Ads (VRNA) | 1.3 | $10M | 107k | 94.58 | |
| Natera (NTRA) | 1.2 | $9.7M | 58k | 168.94 | |
| UnitedHealth (UNH) | 1.2 | $9.5M | 30k | 311.97 | |
| Axsome Therapeutics (AXSM) | 1.2 | $9.5M | 91k | 104.39 | |
| Cardinal Health (CAH) | 1.2 | $9.2M | 55k | 168.00 | |
| BioMarin Pharmaceutical (BMRN) | 1.0 | $8.2M | 150k | 54.97 | |
| Abbott Laboratories (ABT) | 1.0 | $8.0M | 59k | 136.01 | |
| Ionis Pharmaceuticals (IONS) | 0.9 | $7.2M | 182k | 39.51 | |
| Oscar Health Cl A (OSCR) | 0.8 | $6.7M | 312k | 21.44 | |
| Molina Healthcare (MOH) | 0.8 | $6.6M | 22k | 297.90 | |
| Merus N V (MRUS) | 0.8 | $6.1M | 116k | 52.60 | |
| Alcon Ord Shs (ALC) | 0.8 | $6.0M | 68k | 88.09 | |
| Dynavax Technologies Corp Com New (DVAX) | 0.7 | $5.6M | 565k | 9.92 | |
| Penumbra (PEN) | 0.7 | $5.5M | 22k | 256.63 | |
| Centene Corporation (CNC) | 0.7 | $5.4M | 100k | 54.28 | |
| Syndax Pharmaceuticals (SNDX) | 0.7 | $5.4M | 574k | 9.37 | |
| Bruker Corporation (BRKR) | 0.6 | $5.1M | 123k | 41.20 | |
| Anteris Technologies Global (AVR) | 0.6 | $4.7M | 1.3M | 3.79 | |
| Astrana Health Com New (ASTH) | 0.6 | $4.7M | 190k | 24.88 | |
| Universal Hlth Svcs CL B (UHS) | 0.6 | $4.7M | 26k | 181.15 | |
| Stryker Corporation (SYK) | 0.6 | $4.5M | 12k | 395.63 | |
| Thermo Fisher Scientific (TMO) | 0.6 | $4.5M | 11k | 405.46 | |
| Arcellx Common Stock (ACLX) | 0.6 | $4.4M | 67k | 65.85 | |
| Edwards Lifesciences (EW) | 0.5 | $4.3M | 55k | 78.21 | |
| Tg Therapeutics (TGTX) | 0.5 | $4.1M | 115k | 35.99 | |
| Nuvalent Inc-a (NUVL) | 0.5 | $4.0M | 53k | 76.30 | |
| Inspire Med Sys (INSP) | 0.5 | $4.0M | 31k | 129.77 | |
| Biontech Se Sponsored Ads (BNTX) | 0.5 | $3.8M | 36k | 106.47 | |
| Cytokinetics Com New (CYTK) | 0.4 | $3.4M | 104k | 33.04 | |
| Ultragenyx Pharmaceutical (RARE) | 0.4 | $3.4M | 93k | 36.36 | |
| Mirum Pharmaceuticals (MIRM) | 0.4 | $3.3M | 66k | 50.89 | |
| Structure Therapeutics Sponsored Ads (GPCR) | 0.4 | $2.8M | 135k | 20.74 | |
| RadNet (RDNT) | 0.3 | $2.6M | 46k | 56.91 | |
| Vericel (VCEL) | 0.3 | $2.5M | 58k | 42.55 | |
| Repligen Corporation (RGEN) | 0.3 | $2.4M | 20k | 124.38 | |
| Livanova SHS (LIVN) | 0.3 | $2.4M | 53k | 45.02 | |
| Dianthus Therapeutics (DNTH) | 0.3 | $2.4M | 127k | 18.63 | |
| Viking Therapeutics (VKTX) | 0.3 | $2.3M | 85k | 26.50 | |
| Moonlake Immunotherapeutics Class A Ord (MLTX) | 0.3 | $2.1M | 45k | 47.20 | |
| Nurix Therapeutics (NRIX) | 0.3 | $2.1M | 185k | 11.39 | |
| Privia Health Group (PRVA) | 0.3 | $2.1M | 91k | 23.00 | |
| Iqvia Holdings (IQV) | 0.3 | $2.0M | 13k | 157.59 | |
| Krystal Biotech (KRYS) | 0.2 | $1.8M | 13k | 137.46 | |
| Summit Therapeutics (SMMT) | 0.2 | $1.7M | 78k | 21.28 | |
| Apellis Pharmaceuticals (APLS) | 0.2 | $1.6M | 93k | 17.31 | |
| Relay Therapeutics (RLAY) | 0.2 | $1.6M | 460k | 3.46 | |
| Biogen Idec (BIIB) | 0.2 | $1.5M | 12k | 125.59 | |
| Kura Oncology (KURA) | 0.2 | $1.4M | 250k | 5.77 | |
| Denali Therapeutics (DNLI) | 0.2 | $1.4M | 100k | 13.99 | |
| Xencor (XNCR) | 0.2 | $1.3M | 166k | 7.86 | |
| Doximity Cl A (DOCS) | 0.2 | $1.3M | 21k | 61.34 | |
| Janux Therapeutics (JANX) | 0.2 | $1.3M | 55k | 23.10 | |
| Alkermes SHS (ALKS) | 0.1 | $1.1M | 39k | 28.61 | |
| Iovance Biotherapeutics (IOVA) | 0.1 | $1.1M | 648k | 1.72 | |
| Annexon (ANNX) | 0.1 | $1.1M | 460k | 2.40 | |
| Xenon Pharmaceuticals (XENE) | 0.1 | $1.1M | 35k | 31.30 | |
| Immunocore Hldgs Ads (IMCR) | 0.1 | $887k | 28k | 31.38 | |
| Bio-techne Corporation (TECH) | 0.1 | $772k | 15k | 51.45 | |
| Inmune Bio Ord (INMB) | 0.1 | $412k | 178k | 2.31 |
